Skip to main content
Caplight Logo









Outer Biosciences

Outer Biosciences

Private
Malden, MassachusettsHealthcare & Life Scienceshttps://outerbio.com/

Last Round

Early Funding

Aug 22, 2026

Total Funding Raised

$23M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Outer Biosciences is a biotechnology company that utilizes artificial intelligence and living human skin tissue models to discover and develop novel bioactive compounds for skincare and pharmaceutical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Fashion & Beauty, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

ex vivo skinbioactive discoverydermatological researchin vitro testingdrug discoveryAI drug discoverycosmetic R&Dpredictive modelinghuman tissue modelsskin healthanimal-free testingbio-techR&D servicesclinical validationlab-grown skin

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Outer Biosciences Comparables

Compare Outer Biosciences with similar companies based on industry and business-model similarity.

Outer Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ten Bio Ltd
87%
Stratum Biosciences
84%
Genoskin
84%

Outer Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingAug 22, 2026
SeedMar 14, 2022

Key People

Founding team and executive leadership

Chris Hinojosa

Co-Founder and Chief Technology Officer

Founding Team

Kyung-Jin Jang

Co-founder & Chief Scientific Officer

Founding Team

Stanley King

Co-Founder and Chief Business Officer

Founding Team

Michael Polansky

Co-Founder And CEO

Founding Team

Outer Biosciences Investors

Notable investors and investment history

Outer Biosciences investors
InvestorRounds
SV AngelEarly Funding
Calm CapitalSeed
Hawktail ManagementEarly Funding, Seed
Initialized Capital ManagementEarly Funding
Wing Venture CapitalEarly Funding
Sozo VenturesEarly Funding
Third Kind Venture CapitalEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    $19M round led by Wing Venture Capital.

  • Aug 1, 2026

    Grew 21% QoQ from 19 to 23 employees.

Outer Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Outer Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Outer Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersMalden, Massachusetts
Employee Range23
Year Founded2020
Last FundingAug 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?